Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 86

1.

A simple self-reported adherence tool as a predictor of viral rebound in people with viral suppression on antiretroviral therapy.

O'Connor JL, Gardner EM, Esser S, Mannheimer SB, Lifson AR, Telzak EE, Phillips AN; International Network for Strategic Initiatives in Global HIV Trials (INSIGHT) Strategies for Management of Antiretroviral Therapy (SMART) Study Group.

HIV Med. 2015 Jul 17. doi: 10.1111/hiv.12284. [Epub ahead of print]

PMID:
26186609
2.

Quality of life assessment among HIV-positive persons entering the INSIGHT Strategic Timing of AntiRetroviral Treatment (START) trial.

Lifson AR, Grandits GA, Gardner EM, Wolff MJ, Pulik P, Williams I, Burman WJ; International Network for Strategic Initiatives in Global HIV Trials (INSIGHT) START Study Group.

HIV Med. 2015 Apr;16 Suppl 1:88-96. doi: 10.1111/hiv.12237.

PMID:
25711327
3.

Re: "Lessons learned from the design and implementation of myocardial infarction adjudication tailored for HIV clinical cohorts".

Lifson AR, Nelson R, Prineas RJ, Duprez D.

Am J Epidemiol. 2014 Aug 15;180(4):449. doi: 10.1093/aje/kwu165. Epub 2014 Jul 2. No abstract available.

4.

Failure to test for HIV in rural Ethiopia: knowledge and belief correlates and implications for universal test and treat strategies.

Lifson AR, Demisse W, Ketema K, Tadesse A, May R, Yakob B, Slater L, Shenie T.

J Int Assoc Provid AIDS Care. 2013 Sep-Oct;12(5):306-11. doi: 10.1177/2325957413488199. Epub 2013 Jun 6.

PMID:
23744773
5.

Factors associated with adherence amongst 5295 people receiving antiretroviral therapy as part of an international trial.

O'Connor JL, Gardner EM, Mannheimer SB, Lifson AR, Esser S, Telzak EE, Phillips AN; INSIGHT SMART Study Group.

J Infect Dis. 2013 Jul;208(1):40-9. doi: 10.1093/infdis/jis731. Epub 2012 Nov 29.

6.

Barriers to retention in care as perceived by persons living with HIV in rural Ethiopia: focus group results and recommended strategies.

Lifson AR, Demissie W, Tadesse A, Ketema K, May R, Yakob B, Metekia M, Slater L, Shenie T.

J Int Assoc Provid AIDS Care. 2013 Jan-Feb;12(1):32-8. doi: 10.1177/1545109712456428. Epub 2012 Sep 19.

PMID:
22993233
7.

Smoking and HIV: prevalence, health risks, and cessation strategies.

Lifson AR, Lando HA.

Curr HIV/AIDS Rep. 2012 Sep;9(3):223-30. doi: 10.1007/s11904-012-0121-0. Review.

PMID:
22618079
8.

Results of a 25-year longitudinal analysis of the serologic incidence of syphilis in a cohort of HIV-infected patients with unrestricted access to care.

Ganesan A, Fieberg A, Agan BK, Lalani T, Landrum ML, Wortmann G, Crum-Cianflone NF, Lifson AR, Macalino G; Infectious Disease Clinical Research Program HIV Working Group.

Sex Transm Dis. 2012 Jun;39(6):440-8. doi: 10.1097/OLQ.0b013e318249d90f.

9.

HIV/AIDS stigma-associated attitudes in a rural Ethiopian community: characteristics, correlation with HIV knowledge and other factors, and implications for community intervention.

Lifson AR, Demissie W, Tadesse A, Ketema K, May R, Yakob B, Metekia M, Slater L, Shenie T.

BMC Int Health Hum Rights. 2012 May 3;12:6. doi: 10.1186/1472-698X-12-6.

10.

Clinical, demographic and laboratory parameters at HAART initiation associated with decreased post-HAART survival in a U.S. military prospective HIV cohort.

Lifson AR, Krantz EM, Grambsch PL, Macalino GE, Crum-Cianflone NF, Ganesan A, Okulicz JF, Eaton A, Powers JH, Eberly LE, Agan BK; Infectious Disease Clinical Research Program HIV/STI Working Group.

AIDS Res Ther. 2012 Feb 10;9(1):4. doi: 10.1186/1742-6405-9-4.

11.

Gonorrhoea or chlamydia in a U.S. military HIV-positive cohort.

Spaulding AB, Lifson AR, Iverson ER, Ganesan A, Landrum ML, Weintrob AC, Agan BK, Bavaro MF, O'Connell RJ, Macalino GE; Infectious Disease Clinical Research Program HIV Working Group.

Sex Transm Infect. 2012 Jun;88(4):266-71. doi: 10.1136/sextrans-2011-050173. Epub 2012 Jan 4.

PMID:
22223813
12.

Haemoglobin and anaemia in the SMART study.

Mocroft A, Lifson AR, Touloumi G, Neuhaus J, Fox Z, Palfreeman A, Vjecha MJ, Hodder S, De Wit S, Lundgren JD, Phillips AN; INSIGHT SMART Study Group.

Antivir Ther. 2011;16(3):329-37. doi: 10.3851/IMP1746.

13.

Early postseroconversion CD4 cell counts independently predict CD4 cell count recovery in HIV-1-postive subjects receiving antiretroviral therapy.

Kulkarni H, Okulicz JF, Grandits G, Crum-Cianflone NF, Landrum ML, Hale B, Wortmann G, Tramont E, Polis M, Dolan M, Lifson AR, Agan BK, Ahuja SK, Marconi VC.

J Acquir Immune Defic Syndr. 2011 Aug 15;57(5):387-95. doi: 10.1097/QAI.0b013e3182219113.

14.

Telephone survey assessment of household patterns of influenza vaccination, Twin Cities seven county metro area, 2008-2009.

Robien MA, Lifson AR, Duval S, Nichol KL, Ferrieri P.

Vaccine. 2011 May 23;29(23):4033-42. doi: 10.1016/j.vaccine.2011.03.045. Epub 2011 Mar 29.

PMID:
21453787
15.

Long-term CD4+ lymphocyte response following HAART initiation in a U.S. Military prospective cohort.

Lifson AR, Krantz EM, Eberly LE, Dolan MJ, Marconi VC, Weintrob AC, Crum-Cianflone NF, Ganesan A, Grambsch PL, Agan BK; Infectious Disease Clinical Research Program (IDCRP) HIV Working Group.

AIDS Res Ther. 2011 Jan 18;8(1):2. doi: 10.1186/1742-6405-8-2.

16.

Development of diagnostic criteria for serious non-AIDS events in HIV clinical trials.

Lifson AR; INSIGHT Endpoint Review Committee Writing Group, Belloso WH, Davey RT, Duprez D, Gatell JM, Hoy JF, Krum EA, Nelson R, Pedersen C, Perez G, Price RW, Prineas RJ, Rhame FS, Sampson JH, Worley J, INSIGHT Study Group.

HIV Clin Trials. 2010 Jul-Aug;11(4):205-19. doi: 10.1310/hct1104-205.

17.

Smoking-related health risks among persons with HIV in the Strategies for Management of Antiretroviral Therapy clinical trial.

Lifson AR, Neuhaus J, Arribas JR, van den Berg-Wolf M, Labriola AM, Read TR; INSIGHT SMART Study Group.

Am J Public Health. 2010 Oct;100(10):1896-903. doi: 10.2105/AJPH.2009.188664. Epub 2010 Aug 19.

18.

Epidemiology of Hepatitis B virus infection in a US cohort of HIV-infected individuals during the past 20 years.

Chun HM, Fieberg AM, Hullsiek KH, Lifson AR, Crum-Cianflone NF, Weintrob AC, Ganesan A, Barthel RV, Bradley WP, Agan BK, Landrum ML; Infectious Disease Clinical Research Program HIV Working Group.

Clin Infect Dis. 2010 Feb 1;50(3):426-36. doi: 10.1086/649885.

19.

A training program for nurses and other health professionals in rural-based settings on screening and clinical management of HIV and other sexually transmitted infections.

Lifson AR, Rybicki SL, Hadsall C, Dickinson S, Van Zyl A, Carr P.

J Assoc Nurses AIDS Care. 2009 Jan-Feb;20(1):77-85. doi: 10.1016/j.jana.2008.09.008.

PMID:
19118774
20.

Determination of the underlying cause of death in three multicenter international HIV clinical trials.

Lifson AR; INSIGHT Cause of Death Writing Group, Belloso WH, Carey C, Davey RT, Duprez D, El-Sadr WM, Gatell JM, Gey DC, Hoy JF, Krum EA, Nelson R, Nixon DE, Paton N, Pedersen C, Perez G, Price RW, Prineas RJ, Rhame FS, Sampson J, Worley J.

HIV Clin Trials. 2008 May-Jun;9(3):177-85. doi: 10.1310/hct0903-177.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk